Related Experiment Video

Updated: Dec 23, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

744

β-Sitosterol Protects against Myocardial Ischemia/Reperfusion Injury via Targeting PPARγ/NF-κB Signalling

Fengxia Lin1, Luhua Xu1, Meizhu Huang1

  • 1Department of Cardiology, Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, The Affiliated Hospital of Guangzhou University of Chinese Medicine, Shenzhen 518133, China.

Evidence-Based Complementary and Alternative Medicine : Ecam
|April 21, 2020
PubMed

Insights

Beta-sitosterol protects heart cells from injury caused by ischemia/reperfusion (I/R). This compound may modulate PPARγ/NF-κB signaling, offering a potential therapeutic strategy for heart attack patients.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Myocardial ischemia/reperfusion (I/R) injury is a severe complication of myocardial infarction, leading to significant disability and mortality.
  • The precise molecular mechanisms driving I/R injury remain incompletely understood, necessitating further investigation into potential therapeutic targets.

Purpose of the Study:

  • To investigate the cardioprotective effects of beta-sitosterol against I/R injury.
  • To elucidate the molecular pathways through which beta-sitosterol exerts its protective effects.

Main Methods:

  • In vitro studies utilized hypoxia/reoxygenation (H/R) to induce cardiomyocyte injury, assessing cell viability, apoptosis, reactive oxygen species (ROS), caspase activity, and mitochondrial membrane potential.
  • In vivo studies employed an I/R rat model to evaluate infarct size and apoptosis.
  • The role of peroxisome proliferator-activated receptor gamma (PPARγ) and nuclear factor-kappa B (NF-κB) signaling pathways was examined, including the use of PPARγ inhibitors.

Main Results:

  • H/R treatment induced significant cardiomyocyte injury, including reduced viability, increased apoptosis, elevated ROS, and altered mitochondrial function.
  • Beta-sitosterol treatment effectively attenuated H/R-induced cardiomyocyte damage.
  • Beta-sitosterol counteracted H/R-induced suppression of PPARγ and enhanced NF-κB expression, with PPARγ inhibition diminishing beta-sitosterol's protective effects.
  • In I/R rats, beta-sitosterol reduced infarct size and apoptosis, effects that were blunted by PPARγ inhibition.

Conclusions:

  • Beta-sitosterol demonstrates significant cardioprotective effects against both in vitro H/R and in vivo myocardial I/R injury.
  • The cardioprotective mechanisms of beta-sitosterol appear to involve the modulation of the PPARγ/NF-κB signaling pathway.
  • Further research is warranted to explore the clinical applicability of beta-sitosterol for managing myocardial I/R injury.

More Related Videos

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

6.9K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.2K

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.4K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.2K